Simon Beaulieu-Bonneau

Prof. Simon Beaulieu-Bonneau

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2012 in Sleep Medicine Reviews
Verified
Journal Article
Closed access
ÉFÉmilie Fortier-Brochu
Émilie Fortier-Brochu
SBSimon Beaulieu-Bonneau
Simon Beaulieu-Bonneau
HIHans Ivers
Hans Ivers
CMCharles M. Morin
Charles M. Morin

1 August 2007 in Journal of Psychosomatic Research
Verified
Journal Article
Closed access
MLMélanie LeBlanc
Mélanie LeBlanc
SBSimon Beaulieu-Bonneau
Simon Beaulieu-Bonneau
CMChantal Mérette
Chantal Mérette
JSJosée Savard
Josée Savard
HIHans Ivers
Hans Ivers
CMCharles M. Morin
Charles M. Morin

1 May 2006 in Journal of Head Trauma Rehabilitation
Verified
Journal Article
Closed access
MOMarie-Christine Ouellet
Marie-Christine Ouellet
SBSimon Beaulieu-Bonneau
Simon Beaulieu-Bonneau
CMCharles M. Morin
Charles M. Morin
Objectives To document the frequency of insomnia (according to DSM-IV and ICSD criteria), to describe its sociodemographic and clinical characteristics, and to identify potential predictors of insomnia in persons with traumatic brain injury (TBI). Participants and procedure Four hundred fifty-two participants aged 16 years and older with minor to severe TBI answered a questionnaire pertaining to quality of sleep and fatigue. Main outcome measures Proportion of participants fulfilling criteria for insomnia symptoms or syndrome. Validated measures of insomnia severity, fatigue level, and psychologic distress. Results of a logistic regression analysis. Results Overall, 50.2% of the sample reported insomnia symptoms and 29.4% fulfilled the diagnostic criteria for an insomnia syndrome. For the latter participants, insomnia was a severe and chronic condition remaining untreated in almost 60% of cases. Risk factors associated with insomnia were milder TBIs, and higher levels of fatigue, depression, and pain. Conclusion Insomnia is a prevalent condition after TBI requiring more clinical and scientific attention as it may have important repercussions on rehabilitation.

1 January 2021 in Disability and Health Journal
Verified
Journal Article
Closed access
ALAudrey Lebrasseur
Audrey Lebrasseur
NFNoémie Fortin-Bédard
Noémie Fortin-Bédard
JLJosiane Lettre
Josiane Lettre
EBEve-Line Bussières
Eve-Line Bussières
KBKrista Best
Krista Best
François RouthierFrançois Routhier
François Routhier

1 July 2015 in The Lancet Neurology
Verified
Journal Article
Closed access
MOMarie-Christine Ouellet
Marie-Christine Ouellet
SBSimon Beaulieu-Bonneau
Simon Beaulieu-Bonneau
CMCharles M Morin
Charles M Morin

1 August 2014 in Journal of Consulting and Clinical Psychology
Verified
Journal Article
Closed access
AHAllison G. Harvey
Allison G. Harvey
LBLynda Bélanger
Lynda Bélanger
LTLisa Talbot
Lisa Talbot
PEPolina Eidelman
Polina Eidelman
SBSimon Beaulieu-Bonneau
Simon Beaulieu-Bonneau
CMCharles M. Morin
Charles M. Morin
To examine the unique contribution of behavior therapy (BT) and cognitive therapy (CT) relative to the full cognitive behavior therapy (CBT) for persistent insomnia. Participants were 188 adults (117 women; M age = 47.4 years, SD = 12.6) with persistent insomnia (average of 14.5 years duration). They were randomized to 8 weekly, individual sessions consisting of BT (n = 63), CT (n = 65), or CBT (n = 60). Full CBT was associated with greatest improvements, the improvements associated with BT were faster but not as sustained and the improvements associated with CT were slower and sustained. The proportion of treatment responders was significantly higher in the CBT (67.3%) and BT (67.4%) relative to CT (42.4%) groups at post treatment, while 6 months later CT made significant further gains (62.3%), BT had significant loss (44.4%), and CBT retained its initial response (67.6%). Remission rates followed a similar trajectory, with higher remission rates at post treatment in CBT (57.3%) relative to CT (30.8%), with BT falling in between (39.4%); CT made further gains from post treatment to follow up (30.9% to 51.6%). All 3 therapies produced improvements of daytime functioning at both post treatment and follow up, with few differential changes across groups. Full CBT is the treatment of choice. Both BT and CT are effective, with a more rapid effect for BT and a delayed action for CT. These different trajectories of changes provide unique insights into the process of behavior change via behavioral versus cognitive routes.